Yipinhong Pharmaceutical Co Ltd Class A Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Yipinhong Pharmaceutical Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥14.81 Million ≈ $2.17 Million USD) by net assets (CN¥1.80 Billion ≈ $263.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

Cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Yipinhong Pharmaceutical Co Ltd Class A for real-time trading data and today's change.

Yipinhong Pharmaceutical Co Ltd Class A Cash Flow Conversion Ratio Explained

Yipinhong Pharmaceutical Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Yipinhong Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Also see 300723 company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
COUNTRY GARDEN SVDL-0001
F:75H
N/A
SIRIUS REAL ESTATE LTD.
F:EYI
N/A
Tatung Co
TW:2371
-0.009x
Himax Technologies Inc
NASDAQ:HIMX
0.019x
Kent Gida Maddeleri Sanayi ve Ticaret AS
IS:KENT
-0.536x
German American Bancorp Inc
NASDAQ:GABC
0.048x
ALPEK S.A.B. de C.V
MX:ALPEKA
0.099x
EMEIS SA
PA:EMEIS
0.441x

Annual Cash Flow Conversion Efficiency for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. Review how much free cash does Yipinhong Pharmaceutical Co Ltd Class A generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.41 Billion
≈ $205.84 Million
CN¥46.01 Million
≈ $6.73 Million
0.033x +111.50%
2024-12-31 CN¥1.94 Billion
≈ $283.28 Million
CN¥-550.42 Million
≈ $-80.54 Million
-0.284x -261.26%
2023-12-31 CN¥2.60 Billion
≈ $380.16 Million
CN¥458.05 Million
≈ $67.03 Million
0.176x -19.70%
2022-12-31 CN¥2.17 Billion
≈ $316.92 Million
CN¥475.53 Million
≈ $69.59 Million
0.220x +1.16%
2021-12-31 CN¥2.02 Billion
≈ $295.35 Million
CN¥438.10 Million
≈ $64.11 Million
0.217x +17.91%
2020-12-31 CN¥1.50 Billion
≈ $218.77 Million
CN¥275.22 Million
≈ $40.27 Million
0.184x -12.06%
2019-12-31 CN¥1.34 Billion
≈ $196.17 Million
CN¥280.65 Million
≈ $41.07 Million
0.209x +14.00%
2018-12-31 CN¥1.30 Billion
≈ $190.13 Million
CN¥238.60 Million
≈ $34.91 Million
0.184x +44.01%
2017-12-31 CN¥1.11 Billion
≈ $162.20 Million
CN¥141.35 Million
≈ $20.68 Million
0.128x -70.61%
2016-12-31 CN¥336.50 Million
≈ $49.24 Million
CN¥146.01 Million
≈ $21.37 Million
0.434x +152.00%
2015-12-31 CN¥200.66 Million
≈ $29.36 Million
CN¥34.55 Million
≈ $5.06 Million
0.172x +151.17%
2014-12-31 CN¥127.52 Million
≈ $18.66 Million
CN¥8.74 Million
≈ $1.28 Million
0.069x -90.62%
2013-12-31 CN¥185.61 Million
≈ $27.16 Million
CN¥135.68 Million
≈ $19.85 Million
0.731x --

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.87 Billion
CN¥12.75 Billion CNY
Market Cap Rank
#6144 Global
#1132 in China
Share Price
CN¥28.22
Change (1 day)
-0.60%
52-Week Range
CN¥27.66 - CN¥53.76
All Time High
CN¥80.53
About

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale a… Read more